Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Cellular Biochemistry

• Publication date

  2012-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jcb.24134PMID 22415970
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling.

  2011cited by this paper
• Chemosensitization of tumors by resveratrol

  2011cited by this paper
• Global cancer statistics

  2011influential reference
• Resveratrol induces cell‐cycle disruption and apoptosis in chemoresistant B16 melanoma

  2010cited by this paper
• Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines.

  2010cited by this paper
• Resveratrol: cellular actions of a potent natural chemical that confers a diversity of health benefits.

  2009cited by this paper
• Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.

  2009cited by this paper
• Resveratrol and chemoprevention.

  2009cited by this paper
• Induction of a reversible, non‐cytotoxic S‐phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection

  2009cited by this paper
• Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.

  2008cited by this paper
• Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells

  2008cited by this paper
• Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: The roles of caspase-6 and p53

  2008cited by this paper
• Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.

  2007cited by this paper
• Multiple molecular mechanisms for multidrug resistance transporters

  2007cited by this paper
• Therapeutic potential of resveratrol: the in vivo evidence

  2006cited by this paper
• Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells.

  2006cited by this paper
• Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins

  2006cited by this paper
• Cell Cycle Sibling Rivalry: Cdc2 Versus Cdk2

  2005cited by this paper
• Cell cycle sibling rivalry: Cdc2 vs. Cdk2.

  2005cited by this paper
• Mammalian cyclin-dependent kinases.

  2005cited by this paper
• Chemosensitization and Radiosensitization of Tumors by Plant Polyphenols

  2005cited by this paper
• Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo.

  2004cited by this paper
• Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol

  2004cited by this paper
• Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells.

  2004cited by this paper
• The Chk2 protein kinase.

  2004cited by this paper
• Resveratrol Inhibits Drug-Induced Apoptosis in Human Leukemia Cells by Creating an Intracellular Milieu Nonpermissive for Death Execution

  2004cited by this paper
• Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis.

  2004cited by this paper
• Combined effects of resveratrol and paclitaxel on lung cancer cells.

  2003cited by this paper
• Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells.

  2003cited by this paper
• The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer

  2003influential reference
• Cyclin-Dependent Kinases and S Phase Control in Mammalian Cells

  2003cited by this paper
• The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle.

  2002cited by this paper
• A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol.

  2001cited by this paper
• Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator

  2001cited by this paper
• p21(WAF1/Cip1): more than a break to the cell cycle?

  2000cited by this paper
• Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes

  1997cited by this paper
• Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

  1987cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Resveratrol potentiates chemotherapeutic efficacy of olaparib in MCF7 human breast cancer cells by inducing apoptosis.

  2026cites this paper
• Exploring synergistic effects of bioactive compounds and pharmaceuticals in therapeutic applications

  2026cites this paper
• Stilbenes from Vine Extracts: Therapeutic Potential and Mechanisms

  2025cites this paper
• The Potential of Resveratrol as an Anticancer Agent: Updated Overview of Mechanisms, Applications, and Perspectives

  2025cites this paper
• Breaking Barriers; Phytoestrogens in the Fight Against Triple‐Negative Breast Cancer: A Comprehensive Review

  2025cites this paper
• From Molecules to Medicine: Molecular Dynamics and Docking in Breast Cancer Therapeutics.

  2025cites this paper
• Oxyresveratrol in Breast Cancer Cells: Synergistic Effect with Chemotherapeutics Doxorubicin or Melphalan on Proliferation, Cell Cycle Arrest, and Cell Death

  2024cites this paper
• The small phytomolecule resveratrol: A promising role in boosting tumor cell chemosensitivity

  2024cites this paper
• Curcumin and melphalan cotreatment induces cell cycle arrest and apoptosis in MDA-MB-231 breast cancer cells

  2023cites this paper
• Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy

  2023cites this paper
• Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint

  2022cites this paper
• Targeting Microtubules by Phytoestrogens for the Treatment of Cancer: An Overview

  2022cites this paper
• Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer

  2022cites this paper
• Anti-cancer potential of Tetracarpidium conophorum (African walnut) seed oil on prostate carcinogenesis

  2022cites this paper
• Chemopreventive and Therapeutic Potential of Natural Agents and Their Combinations for Breast Cancer

  2021cites this paper
• Integrative investigation of the TF–miRNA coregulatory network involved in the inhibition of breast cancer cell proliferation by resveratrol

  2021cites this paper
• Calorie Restriction for Cancer Prevention and Therapy: Mechanisms, Expectations, and Efficacy

  2021cites this paper
• Mini Review Integrative Cancer Science and Therapeutics Phytotherapy and oncology. A short review

  2021cites this paper
• Natural compounds as chemosensitizers: A lesson from plants

  2021cites this paper
• Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy

  2021cites this paper
• Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines

  2021cites this paper
• Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways

  2021cites this paper
• Chemo-Preventive Action of Resveratrol: Suppression of p53—A Molecular Targeting Approach

  2021cites this paper
• Enhanced apoptogenesis and oncogene regulatory mechanism of troxerutin in triple negative breast cancer cells.

  2020cites this paper
• Bioactive Compounds and Metabolites from Grapes and Red Wine in Breast Cancer Chemoprevention and Therapy

  2020cites this paper
• Etiology of atherosclerosis informs choice of animal models and tissues for initial functional genomic studies of resveratrol.

  2020cites this paper
• Synergistic effect of curcumin, piperine and resveratrol in MCF-7 and MDA MB-231 breast cancer cells.

  2020cites this paper
• -Role of natural compounds in preventing and treating breast cancer.

  2020cites this paper
• Resveratrol Modifies Lipid Composition of Two Cancer Cell Lines

  2020influential citation
• Resveratrol, Curcumin and Piperine Alter Human Glyoxalase 1 in MCF-7 Breast Cancer Cells

  2020cites this paper
• In Vitro and In Vivo Assessment of Designed Melphalan Loaded Stealth Solid Lipid Nanoparticles for Parenteral Delivery

  2019cites this paper
• A Review of Resveratrol as a Potent Chemoprotective and Synergistic Agent in Cancer Chemotherapy

  2019cites this paper
• The antitumor effect of resveratrol on nasopharyngeal carcinoma cells.

  2019cites this paper
• Epigenetic Dietary Interventions for Prevention of Cancer

  2019cites this paper
• The Anticancer and Antioxidant Effects of Muscadine Grape Extracts on Racially Different Triple-negative Breast Cancer Cells

  2019cites this paper
• Increase in fatty acids and flotillins upon resveratrol treatment of human breast cancer cells

  2019cites this paper
• Phytoestrogens and breast cancer: In vitro anticancer activities of isoflavones, lignans, coumestans, stilbenes and their analogs and derivatives.

  2018cites this paper
• Resveratrol inhibits cell viability and proliferation via apoptotic pathways in ovarian cancer

  2018cites this paper
• Preparation and in vitro–in vivo characterization of trans-resveratrol nanosuspensions

  2018cites this paper
• Resveratrol: A Miracle Drug for Vascular Pathologies

  2018cites this paper
• Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives

  2018cites this paper
• The functional genomic studies of resveratrol in respect to its anti-cancer effects.

  2018cites this paper
• Prevention of Breast Cancer by Natural Phytochemicals: Focusing on Molecular Targets and Combinational Strategy

  2018cites this paper
• In vitro and in vivo anti-inflammatory properties of imine resveratrol analogues.

  2018cites this paper
• Resveratrol as MDR reversion molecule in breast cancer: An overview.

  2017cites this paper
• Pro-oxidant and pro-apoptotic activity of polyphenol extract from Annurca apple and its underlying mechanisms in human breast cancer cells.

  2017cites this paper
• The Role of Resveratrol in Cancer Therapy

  2017cites this paper
• The comparative study among different fractions of muscadine grape ‘Noble’ pomace extracts regarding anti-oxidative activities, cell cycle arrest and apoptosis in breast cancer

  2017cites this paper
• Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target

  2017cites this paper
• Phenolic Fractions from Muscadine Grape "Noble" Pomace can Inhibit Breast Cancer Cell MDA-MB-231 Better than those from European Grape "Cabernet Sauvignon" and Induce S-Phase Arrest and Apoptosis.

  2017cites this paper
• Overview of common dietary phytochemicals possessing antioxidant properties through Nrf2

  2016cites this paper
• Characterization of the 5'-flanking region of the human TP53 gene and its response to the natural compound, Resveratrol.

  2016cites this paper
• Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer

  2016cites this paper
• Unraveling the Anticancer Effect of Curcumin and Resveratrol

  2016cites this paper
• Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms.

  2016cites this paper
• of doxorubicin in solid tumor cells by methyl-β-cyclodextrin : Involvement of p 53 and Fas receptor ligand complex

  2015cites this paper
• Resveratrol Enhances Etoposide‐Induced Cytotoxicity through Down‐Regulating ERK1/2 and AKT‐Mediated X‐ray Repair Cross‐Complement Group 1 (XRCC1) Protein Expression in Human Non‐Small‐Cell Lung Cancer Cells

  2015cites this paper
• Properties and molecular mechanisms of resveratrol: a review.

  2015cites this paper
• Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex

  2015cites this paper
• Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells.

  2015cites this paper
• Role of Natural Stilbenes in the Prevention of Cancer

  2015cites this paper
• Resveratrol contributes to chemosensitivity of malignant mesothelioma cells with activation of p53.

  2014cites this paper
• Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo

  2014cites this paper
• Role of natural phenolic compounds in cancer chemoprevention via regulation of the cell cycle.

  2014cites this paper
• Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.

  2014cites this paper
• Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells

  2013cites this paper
• Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways.

  2013cites this paper
• Polyphenolic Compounds Targeting p53-Family Tumor Suppressors: Current Progress and Challenges

  2013cites this paper
• Malvidin, a red wine polyphenol, modulates mammalian myocardial and coronary performance and protects the heart against ischemia/reperfusion injury.

  2013cites this paper
• Use of Grape Polyphenols Against Carcinogenesis: Putative Molecular Mechanisms of Action Using In Vitro and In Vivo Test Systems

  2013influential citation
• Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence

  2013cites this paper
• The effect of resveratrol in combination with irradiation and chemotherapy

  2013cites this paper
• Engineering of polyphenol metabolism in tomatoes to enhance anti-cancer activities

  2013cites this paper
• REAL-TIME ANALYSIS OF QUERCETIN, RESVERATROL AND /OR DOXORUBICIN EFFECTS IN MCF-7 CELLS

  2013cites this paper
• Natural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents.

  2013cites this paper
• Natural Polyphenols and Apoptosis Induction in Cancer Therapy

  2013cites this paper
• A potential role for resveratrol as a radiation sensitizer for melanoma treatment.

  2013cites this paper
• Targeting the NF-κB pathway in cancer therapy.

  2013cites this paper
• Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.

  2013cites this paper
• Resveratrol Inhibits the Growth of Gastric Cancer by Inducing G1 Phase Arrest and Senescence in a Sirt1-Dependent Manner

  2013cites this paper
• Anti-carcinogenic effects of Morinda citrifolia (noni) : identifying signal transduction pathways using ER positive and ER negative human breast cancer cell lines

  2012cites this paper
• Resveratrol Induces Apoptosis through PI3K/Akt and p53 Signal Pathway in MDA-MB-231 Breast Cancer Cells

  2012cites this paper
• Resveratrol Induces Apoptosis through PI3K/Akt and p53 Signal Pathway in MDA-MB-231 Breast Cancer Cells

  2012cites this paper
• Apoptosis and autophagy induction as mechanism of cancer prevention by naturally occurring dietary agents.

  2012influential citation
• Transient Transfection of a Wild-Type p53 Gene Triggers Resveratrol-Induced Apoptosis in Cancer Cells

  2012cites this paper